Your browser is no longer supported. Please, upgrade your browser.
XBI SPDR S&P Biotech ETF monthly Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week5.13%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month15.13%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter20.86%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y26.29%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year40.74%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range62.94 - 127.81 Perf YTD38.24%
Dividend0.12 P/FCF- EPS past 5Y- ROI- 52W High2.87% Beta-
Dividend %0.09% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low108.90% ATR3.14
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)72.34 Volatility2.00% 2.67%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.50 Prev Close126.82
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume4.72M Price131.48
Recom- SMA207.59% SMA5011.26% SMA20025.64% Volume2,366,247 Change3.67%
Nov-27-20 08:04AM  
Nov-16-20 08:45AM  
Nov-09-20 08:40AM  
Oct-14-20 04:14PM  
Sep-21-20 11:33AM  
Sep-18-20 12:00AM  
Sep-09-20 06:00PM  
Aug-26-20 11:25AM  
Jul-23-20 04:42PM  
Jun-30-20 04:47PM  
Jun-28-20 04:51PM  
Jun-24-20 05:55PM  
Jun-20-20 12:11PM  
Jun-11-20 04:07PM  
Jun-09-20 09:55AM  
Jun-02-20 04:55PM  
Jun-01-20 08:03AM  
May-22-20 07:46AM  
May-20-20 01:30PM  
May-19-20 09:40AM  
May-18-20 02:47PM  
May-16-20 01:34PM  
May-15-20 11:31AM  
May-13-20 12:31PM  
May-08-20 11:05AM  
May-05-20 03:11PM  
Apr-26-20 04:37PM  
Apr-23-20 10:50AM  
Apr-14-20 03:27PM  
Apr-09-20 03:48PM  
Apr-05-20 02:03PM  
Mar-18-20 08:45AM  
Mar-02-20 03:26PM  
Feb-11-20 05:25PM  
Feb-06-20 05:50PM  
Feb-05-20 08:58AM  
Feb-03-20 01:30PM  
Jan-27-20 10:00AM  
Jan-26-20 07:17PM  
Jan-24-20 03:08PM  
Jan-23-20 04:15PM  
Jan-22-20 03:10PM  
Jan-20-20 02:18PM  
Jan-17-20 01:42PM  
Jan-13-20 07:58AM  
Jan-10-20 08:52AM  
Jan-07-20 01:58PM  
Jan-03-20 10:44AM  
Jan-02-20 10:00AM  
Dec-31-19 12:19PM  
Dec-25-19 11:26AM  
Dec-24-19 12:15PM  
Dec-23-19 02:47PM  
Dec-20-19 01:41PM  
Dec-19-19 07:05AM  
Dec-18-19 02:01PM  
Dec-15-19 07:06PM  
Dec-12-19 04:59PM  
Dec-11-19 08:59AM  
Dec-10-19 04:16PM  
Dec-09-19 11:10AM  
Dec-06-19 01:00PM  
Dec-02-19 02:40PM  
Nov-27-19 06:52AM  
Nov-26-19 07:06PM  
Nov-25-19 02:48PM  
Nov-18-19 10:12AM  
Nov-14-19 01:31PM  
Nov-12-19 10:10AM  
Nov-08-19 02:58PM  
Nov-05-19 08:32AM  
Nov-04-19 05:05PM  
Oct-30-19 10:43AM  
Oct-24-19 11:47AM  
Oct-23-19 04:24PM  
Oct-11-19 10:45AM  
Sep-20-19 11:04AM  
Sep-18-19 01:01PM  
Sep-09-19 02:09PM  
Sep-05-19 03:36PM  
Sep-04-19 10:52AM  
Sep-03-19 05:46PM  
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").